Healthcare and Medical Devices: AI Visibility Market Discovery Index

Benchmark Summary

Questions This Section Answers

• Which brand leads the Healthcare and Medical Devices benchmark, and by how much?
• Did any tracked diabetes care brand post a significant coverage change in October 2026?

Abbott FreeStyle leads the Healthcare and Medical Devices benchmark with a valid recommendation coverage of 61.2% in October 2026, 21.5 points ahead of the second-place brand, Ascensia CONTOUR, at 39.7%. Measured against the July 2026 baseline, Abbott FreeStyle's coverage is up 5.6 points (from 55.6%), a move that remained within normal month-to-month variation for the brand. The gap to Ascensia CONTOUR widened from 15.5 points at the July 2026 baseline to 21.5 points in October 2026, though the margin narrowed to 16.1 points in September before widening again in October.

October 2026 was a quiet month for the category: no tracked brand recorded a coverage movement beyond normal variation. Abbott FreeStyle's coverage moved up 2.1 points from September (59.1%) to October (61.2%), its first upward month after a September pullback, though the move did not clear the threshold for a significant change. Across the baseline-to-current series, LifeScan OneTouch gained 2.6 points (10.9% to 13.5%) and Trividia Health gained 0.3 points (0.5% to 0.8%), while Ascensia CONTOUR eased 0.4 points (40.1% to 39.7%) and Roche Accu-Chek eased 0.4 points (28.5% to 28.1%). None of these moves exceeded normal month-to-month variation.

Roche Accu-Chek has moved down in each of the two months since August 2026, as has Prodigy Diabetes Care, though neither streak has crossed the significance threshold.

The benchmark began with 681 prompt-surface observations in October 2026 and produced 363 qualified observations after qualification.

Current Benchmark at a Glance

Qualified surface breadth counts the six canonical AI/search surface families with at least one qualified observation: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. All six families were represented in every month of the series.

For the strategic interpretation of this benchmark, read CiteWorks Studio's analysis of How AI Search Is Recommending Healthcare and Medical Devices

Research Scope and Qualification

The public benchmark is narrower than the raw collection universe by design.

Brand-level percentages use the qualified observations as the public denominator, not the raw collection. AI Visibility Market Discovery Methodology

Current Brand Standings

Questions This Section Answers

• How do the six tracked brands differ on presence, recommendation coverage, and rank-one rate?
• Why does Trividia Health's presence in AI responses fail to convert into recommendation coverage?
• Which brand leads first-position recommendations despite not leading overall coverage?

How to Read the Standings

• Presence rate: share of qualified observations where the brand is mentioned at all.
• Valid recommendation coverage: share of qualified observations where the brand appears in a valid recommendation shortlist.
• Top-three rate: share of qualified observations where the brand appears in the top three recommended positions.
• Rank-one rate: share of qualified observations where the brand is the first recommendation.
• Net sentiment: positive minus negative mention sentiment, scaled.

For formulas and denominator rules, see AI Visibility Market Discovery Metric Definitions.

Trividia Health: Company Snapshot

Trividia Health recorded a 2.2% presence rate in October 2026, but that presence converted into only 0.8% valid recommendation coverage, 0.5% top-three rate, 0.0% rank-one rate, and a net sentiment of 0.5, the lowest net sentiment figure of any tracked brand. The coverage figure moved up slightly from 0.5% at the July 2026 baseline to 0.8% in October 2026, a gain of 0.3 points on a small absolute base of 3 valid recommendation appearances.

Abbott FreeStyle records 61.2% valid recommendation coverage, while Trividia Health stands at 0.8%. The more important issue is what that gap means for Trividia Health's recommendation position: even against Ascensia CONTOUR, the second-place brand, coverage stands at 39.7% versus Trividia Health's 0.8%, and rank-one rate sits at 25.6% for Ascensia CONTOUR versus 0.0% for Trividia Health. Trividia Health's presence in AI responses is not converting into recommendation coverage at a rate comparable to any other tracked brand, including Prodigy Diabetes Care, the next-smallest brand, at 1.4% coverage.

Highest-priority diagnostic: Why is Trividia Health's presence in AI-surfaced responses failing to convert into valid recommendation coverage, top-three placement, or first-choice recommendations at a rate anywhere close to other tracked brands in the category?

Recommendation Coverage Movement

Questions This Section Answers

• Which brands gained or lost recommendation coverage since the July 2026 baseline?
• Are Trividia Health's and Prodigy Diabetes Care's recent month-over-month moves meaningful trends?

There is no largest increase or largest decline subsection this month. Every tracked brand was classified as stable, and no baseline-to-current movement exceeded normal month-to-month variation. LifeScan OneTouch posted the largest prior-to-current move, up 3.3 points from 10.2% in September 2026 to 13.5% in October 2026, which remained within normal variation for that brand.

Trividia Health has moved up in each of the two months since August 2026, reaching 0.8% in October 2026 from 0.2% in August 2026, on a small absolute base of 3 valid recommendation appearances in October 2026 and 1 in August 2026. Prodigy Diabetes Care has moved down in each of the two months since August 2026, easing to 1.4% in October 2026 from 3.0% in August 2026, on 5 valid recommendation appearances in October 2026 and 12 in August 2026. Neither pattern is yet a trend.

Category Leader: Abbott FreeStyle

Abbott FreeStyle held its leadership position at 61.2% valid recommendation coverage, 21.5 points ahead of Ascensia CONTOUR at 39.7% in October 2026. Its presence rate was 91.5% in October 2026, compared with 96.8% at the July 2026 baseline, while its rank-one rate rose to 14.6% from 10.4% over the same span and its top-three rate moved to 53.7% from 51.8%. Abbott FreeStyle recorded 222 valid recommendation appearances in October 2026, the most of any tracked brand.

Recommendation Placement Snapshot

Questions This Section Answers

• How can Abbott FreeStyle lead top-three placement while Ascensia CONTOUR leads rank-one rate?
• What does the gap between top-three rate and rank-one rate reveal about recommendation prominence?

Coverage alone does not show how prominently a brand is recommended. Abbott FreeStyle led top-three placement at 53.7% while Ascensia CONTOUR led rank-one rate at 25.6% in October 2026, showing that the two leaders occupy different positions in the recommendation stack.

Abbott FreeStyle appeared in the top three in more observations than Ascensia CONTOUR, yet Ascensia CONTOUR was the first recommendation in more observations, so similar coverage bands can still hide different first-position rates.

Buyer-Intent Distribution

Questions This Section Answers

• What buyer-intent classes does the benchmark currently measure, and which are missing?
• Are pricing or multi-brand comparison queries represented in the qualified observations?

All qualified observations in each month fell into the Brand Recommendation class, which covers discovery and consideration queries.

The current public series measures the Brand Recommendation class of discovery and does not yet contain qualified observations in the Pricing & Value or Multi-Brand Comparison classes.

Historical Measurement Record

This is an evergreen benchmark URL. New measurements are added to the same report.

Evidence and Source Layer

The benchmark is built from prompt-level observations that retain the query, AI/search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources. Source presence is evidence about the information environment. It is not automatically proof that the source caused the recommendation.

Scope Boundaries

• This public benchmark does not measure market share or attributable sales.
• It does not capture every possible AI response.
• It does not measure organic-search ranking or social mention volume.
• It does not cover private or sponsored channels.
• It does not establish causality from a metric movement alone.

Top 10 Cited Domains

Questions This Section Answers

• Which domains are cited most often across AI platform responses in this category?
• How concentrated are citations, and which tracked brand domains appear in the top 10?

Across all AI platform responses in this measurement period, 5,077 citations were observed across 760 unique domains.

Citations are broadly distributed rather than concentrated: the top 10 domains together account for roughly a third of all citations across 760 unique domains. Two tracked brand domains appear in the top 10, freestyle.abbott at rank 3 and trividiahealth.com at rank 10. The mix is led by a video platform, a general search surface, and two independent review or health-information sites alongside an official regulatory source, showing that AI answers in this vertical draw on both commercial and non-commercial sources.

About This Benchmark

The LLM Authority Index AI Visibility Market Discovery Index tracks how AI search and chat surfaces discover, mention, and recommend brands within a vertical. The Healthcare and Medical Devices index covers six tracked brands across six canonical AI/search surface families, measuring presence, recommendation coverage, placement, and sentiment on a monthly basis.

• AI Visibility Market Discovery Methodology
• AI Visibility Market Discovery Metric Definitions
• AI Visibility Market Discovery Research Standards
• Modeled AI Visibility Authority Value

Get a Company-Level Authority Index

The public industry benchmark shows category-level standings. A company-level Authority Index can go deeper.

Get my free AI Company Index